Fenix ... "Why do you think the company is hiding the data."

Not sure if serious, or tounge-in-cheek, but a VERY interesting and thought provoking question sir. It is either meh, bad, or good. The first two are abvious issues. The last one ("good") could be for a host of reasons, including pending deals, and just simply timing given the original thought of saving it for spring kidney conferences (then Covid).

Personally I want to see the data though, another puzzle piece.

The thoughts of others here have dampened my "expectations" for the web conference this week, though. But I still think we "could" get good kidney data followed by some level of clarification on the path, and maybe some other things (?). The circumstances and timing lead me to believe there is a solid potential for material news. But like others that have been stomped into the ground emotionally by this investment venture over time (some have "tapped out"), I am down-shifting expectations also.

What I do believe whole-heartedly though, is that THIS stock is wayyyyy under-valued, and I will take any morsel of news along the yellow brick road.

Further, with a BTD, safety, and strong past statements about linking partnership to future initiatives, it would not "shock" me if there are some new "cooks" in the kitchen crafting the meal, and "presentation" of the meal. All speculation on my part to be clear, but this has to move forward at some point, and we pretty much KNOW there will be bigger fish involved. When, how, and how communicated, and to what "short" term and "long" term impact for "us"?!

As Tom Petty said ... "the waiting is the hardest part" ... glta